← All organizations

Aptinyx

For profitWebsite ↗

Also known as: Aptinyx | Aptinyx Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Jan 31, 2023

Timeline

2010s

Jun 1, 2015
Aptinyx— Founded

Drugs by trial phase (4 distinct, 9 trials)

Phase 3 (1 own, 0 via acquisition)

nyx-783

Phase 2 (2 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

oxycodone

Indications

Studied for

Recent trials (12)

NCT05447286CollaboratorPhase 1Jan 31, 2023
NCT05181995Lead sponsorPhase 2/Phase 3Dec 13, 2021
NCT04147858Lead sponsorPhase 2Nov 30, 2019
NCT04147858Study directorPhase 2Nov 30, 2019
NCT04148391Lead sponsorPhase 2Nov 1, 2019
NCT04146896Study directorPhase 2Oct 31, 2019
NCT04146896Lead sponsorPhase 2Oct 31, 2019
NCT04044664Lead sponsorPhase 2Jan 25, 2019
NCT03249103Lead sponsorPhase 2Aug 14, 2017
NCT03219320Lead sponsorPhase 2Jun 27, 2017
NCT02834741Study directorPhase 1Jul 1, 2016
NCT02834741Lead sponsorPhase 1Jul 1, 2016

Details

Founded: Evanston, IL, US Jun 1, 2015
Last known activity: Jan 31, 2023